中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
EVALUATION AND ANAL YSIS OF DRUG-USE IN HOSPITALS OF CHINA
2014年
10期
875-878
,共4页
李娟%陈丽娟%胡珊珊%王云枫
李娟%陳麗娟%鬍珊珊%王雲楓
리연%진려연%호산산%왕운풍
年龄相关性白内障%凋亡%Sirt1%p53%FOXO1%山茱萸多糖
年齡相關性白內障%凋亡%Sirt1%p53%FOXO1%山茱萸多糖
년령상관성백내장%조망%Sirt1%p53%FOXO1%산수유다당
Age-related cataract%Apoptosis%Sirt1%p53%FOXO1%Cornel polysaccharide
目的:初步探讨山茱萸多糖治疗年龄相关性白内障的可能机制,为其预防和治疗寻找新的药物和靶点。方法:选用60只昆明大鼠,按体质量随机分为3组,每组20只,分别为对照组(C组)、衰老模型组(A组)和山茱萸多糖给药组(D组)。在相同环境下,C组正常饮食,每日颈背部皮下注射0?9%氯化钠注射液,剂量计算参照其他给药组D-半乳糖给药量;A和D组正常饮食,每日颈背部皮下注射D-半乳糖100 mg/( kg·d);连续皮下注射45 d后,C和A组每日按照等剂量灌药量灌服温开水;D组按照多糖0?4 g/kg灌服山茱萸多糖,连续灌服30 d。试验终期颈椎离断术处死大鼠,4℃迅速取眼分离晶状体置于液氮备用。免疫组化方法检测各组间总超氧化物歧化酶( T-SOD)和总抗氧化能力( T-AOC)的变化,RT-PCR(逆转录cDNA的聚合酶链式扩增反应)检测各组Sirt1、p53和FOXO1 mRNA的表达变化。结果:A组和D组大鼠晶状体中 Sirt1 mRNA的表达较 C组均显著上升( P<0?05、P<0?01),且D组较A组显著上升(P<0?01);A组和D组大鼠晶状体中p53 mRNA的表达较C组显著上升(P均<0?01),而D组较A组显著下降(P<0?05);A组和D组大鼠晶状体中FOXO1 mRNA的表达较C组显著上升(P<0?05、P<0?01),且D组较A组显著上升(P<0?01)。另外A组和D组大鼠晶状体中T-SOD的活性较C组显著上升(P均<0?01),且D组较A组显著上升(P<0?01);A组和D组大晶状体中鼠T-AOC的活性较C组显著上升(P均<0?01),且D较A组显著上升(P<0?01)。结论:山茱萸多糖可能通过调节Sirt1的表达,从而调节下游基因p53和FOXO1的表达,最终抑制或延缓晶状体上皮细胞的凋亡,减缓年龄相关性白内障的进展。
目的:初步探討山茱萸多糖治療年齡相關性白內障的可能機製,為其預防和治療尋找新的藥物和靶點。方法:選用60隻昆明大鼠,按體質量隨機分為3組,每組20隻,分彆為對照組(C組)、衰老模型組(A組)和山茱萸多糖給藥組(D組)。在相同環境下,C組正常飲食,每日頸揹部皮下註射0?9%氯化鈉註射液,劑量計算參照其他給藥組D-半乳糖給藥量;A和D組正常飲食,每日頸揹部皮下註射D-半乳糖100 mg/( kg·d);連續皮下註射45 d後,C和A組每日按照等劑量灌藥量灌服溫開水;D組按照多糖0?4 g/kg灌服山茱萸多糖,連續灌服30 d。試驗終期頸椎離斷術處死大鼠,4℃迅速取眼分離晶狀體置于液氮備用。免疫組化方法檢測各組間總超氧化物歧化酶( T-SOD)和總抗氧化能力( T-AOC)的變化,RT-PCR(逆轉錄cDNA的聚閤酶鏈式擴增反應)檢測各組Sirt1、p53和FOXO1 mRNA的錶達變化。結果:A組和D組大鼠晶狀體中 Sirt1 mRNA的錶達較 C組均顯著上升( P<0?05、P<0?01),且D組較A組顯著上升(P<0?01);A組和D組大鼠晶狀體中p53 mRNA的錶達較C組顯著上升(P均<0?01),而D組較A組顯著下降(P<0?05);A組和D組大鼠晶狀體中FOXO1 mRNA的錶達較C組顯著上升(P<0?05、P<0?01),且D組較A組顯著上升(P<0?01)。另外A組和D組大鼠晶狀體中T-SOD的活性較C組顯著上升(P均<0?01),且D組較A組顯著上升(P<0?01);A組和D組大晶狀體中鼠T-AOC的活性較C組顯著上升(P均<0?01),且D較A組顯著上升(P<0?01)。結論:山茱萸多糖可能通過調節Sirt1的錶達,從而調節下遊基因p53和FOXO1的錶達,最終抑製或延緩晶狀體上皮細胞的凋亡,減緩年齡相關性白內障的進展。
목적:초보탐토산수유다당치료년령상관성백내장적가능궤제,위기예방화치료심조신적약물화파점。방법:선용60지곤명대서,안체질량수궤분위3조,매조20지,분별위대조조(C조)、쇠로모형조(A조)화산수유다당급약조(D조)。재상동배경하,C조정상음식,매일경배부피하주사0?9%록화납주사액,제량계산삼조기타급약조D-반유당급약량;A화D조정상음식,매일경배부피하주사D-반유당100 mg/( kg·d);련속피하주사45 d후,C화A조매일안조등제량관약량관복온개수;D조안조다당0?4 g/kg관복산수유다당,련속관복30 d。시험종기경추리단술처사대서,4℃신속취안분리정상체치우액담비용。면역조화방법검측각조간총초양화물기화매( T-SOD)화총항양화능력( T-AOC)적변화,RT-PCR(역전록cDNA적취합매련식확증반응)검측각조Sirt1、p53화FOXO1 mRNA적표체변화。결과:A조화D조대서정상체중 Sirt1 mRNA적표체교 C조균현저상승( P<0?05、P<0?01),차D조교A조현저상승(P<0?01);A조화D조대서정상체중p53 mRNA적표체교C조현저상승(P균<0?01),이D조교A조현저하강(P<0?05);A조화D조대서정상체중FOXO1 mRNA적표체교C조현저상승(P<0?05、P<0?01),차D조교A조현저상승(P<0?01)。령외A조화D조대서정상체중T-SOD적활성교C조현저상승(P균<0?01),차D조교A조현저상승(P<0?01);A조화D조대정상체중서T-AOC적활성교C조현저상승(P균<0?01),차D교A조현저상승(P<0?01)。결론:산수유다당가능통과조절Sirt1적표체,종이조절하유기인p53화FOXO1적표체,최종억제혹연완정상체상피세포적조망,감완년령상관성백내장적진전。
OBJECTIVE:To discuss the possible mechanism of the dogwood polysaccharide for treatment of age-related cataract in an attempt to find new drugs and target points for its prevention and treatment. METHODS:60 Kunming mice were enrolled in our study and divided into 3 groups of 20 each:Control group( C) , the aging model group(A) and dogwood polysaccharide administration group(D). In the same environment,Group C were fed with normal diet and subcutaneously injected with 0?9% Sodium Chloride Injection in the nape daily as per the dosage of D-galactose in the other administration group; Group A and D were also fed with normal diet and subcutaneously injected with D-galactose 100 mg/( kg·d ) in the nape daily; after subcutaneous injection for 45 consecutive days, Group C and Group A were fed with warm water at the same dose of drug administration; Group D was fed with dogwood polysaccharide at a dose of 0?4 g/kg for polysaccharide for 30 consecutive days. At last all mice were killed by cervical dislocation, with eye lens extracted quickly at 4 ℃ and stored in liquid nitrogen for use. T-SOD and T-AOC were detected by immunohistochemical methods, and Sirt1, p53 and FOXO1 mRNA expressions were detected by RT-PCR. RESULTS:Sirt1 mRNA in disease group and the treatment group increased significantly compared with the control group(P<0?05, P<0?01), and Sirt1 mRNA in the treatment group increased significantly compared with the disease group(P<0?01); p53 mRNA in disease group and the treatment group increased significantly compared with the control group(P<0?01, P<0?01), but p53 mRNA in the treatment group decreased significantly compared with the disease group( P <0?05 ); FOXO1 mRNA in disease group and the treatment group increased significantly compared with the control group ( P <0?05 , P <0?01 ) , and FOXO1 mRNA in the treatment group increased significantly compared with the disease group(P<0?05). Furthermore, T-SOD and T-AOC in the disease group and the treatment group increased significantly compared with the control group ( P <0?01 , P <0?01 ) , and SOD and T-AOC in the treatment group increased significantly compared with the disease group ( P <0?01 , P <0?01 ) . CONCLUSIONS:Dogwood polysaccharide may regulate the expression of downstream genes p53 and FOXO1 possibly by regulating the expression of Sirt1 , ultimately inhibiting or delaying the apoptosis of epithelial cells in eye lens and slow the progression of age-related cataracts.